Abeona Therapeutics ABEO
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Abeona Therapeutics (ABEO) Business Model and Operations Summary
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
Key Insights
Abeona Therapeutics (ABEO) Core Market Data and Business Metrics
Latest Closing Price
$4.68Market Cap
$227.14 MillionPrice-Earnings Ratio
-3.02Total Outstanding Shares
48.53 Million SharesTotal Employees
136Dividend
No dividendIPO Date
September 19, 1980SIC Description
Pharmaceutical PreparationsPrimary Exchange
NASDAQHeadquarters
6555 Carnegie Ave, 4th Floor, Cleveland, OH, 44103
Historical Stock Splits
If you bought 25 shares of ABEO before July 5, 2022, you'd have 1 share today.
| Execution Date | Split Amount |
|---|---|
| July 5, 2022 | 1-for-25 (Reverse Split) |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 394,948 Shares | 6.04 | 3/14/2025 | 2,387,204 Shares |
| 249,700 Shares | 10.09 | 2/28/2025 | 2,519,502 Shares |
| 273,197 Shares | 9.03 | 2/14/2025 | 2,466,957 Shares |
| 271,216 Shares | 9.14 | 1/31/2025 | 2,479,890 Shares |
| 326,695 Shares | 8.15 | 1/15/2025 | 2,663,058 Shares |
| 183,223 Shares | 13.92 | 12/31/2024 | 2,549,739 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow, Continuing | $8.88 Million |
| Net Cash Flow | $8.88 Million |
| Net Cash Flow From Operating Activities | $-56.02 Million |
| Net Cash Flow From Financing Activities | $104.14 Million |
| Net Cash Flow From Investing Activities | $-39.24 Million |
| Net Cash Flow From Financing Activities, Continuing | $104.14 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income/Loss From Continuing Operations Before Tax | $-63.73 Million |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $-34,000 |
| Income/Loss From Continuing Operations After Tax | $-63.73 Million |
| Nonoperating Income/Loss | $1.19 Million |
| Net Income/Loss | $-63.73 Million |
| Preferred Stock Dividends And Other Adjustments | $-34,000 |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss Attributable To Parent | $-63.66 Million |
| Other Comprehensive Income/Loss | $74,000 |
| Comprehensive Income/Loss | $-63.66 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Fixed Assets | $4.43 Million |
| Accounts Payable | $3.44 Million |
| Cash | $98.10 Million |
| Assets | $108.93 Million |
| Other Current Liabilities | $13.15 Million |
| Noncurrent Assets | $8.08 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||